Special Seminar: Prof Adrian Krainer, USA

From Base Pairs to Bedside: Antisense Therapeutics for Splicing Modulation

14 May 2019, 12:00 
Tel Aviv University 
You are invited to attend the Department of Human Molecular Genetics & Biochemistry special seminar, "From Base Pairs to Bedside: Antisense Therapuetics for Splicing Modulation"  with Prof. Adrian Krainer, Cold Spring Harbor Laboratories, USA
Prof. Krainer is a recipient of an honorary award from Tel Aviv University for the invention of the first RNA-targeted antisense therapeutic Spinraza. This is the first drug approved to treat the neurodegenerative disease spinal muscular atrophy 
Date: 14/5/19
Time: 12:00
Location: Lola Hall, Sackler School of Medicine
Host: Gil Ast




Tel Aviv University, P.O. Box 39040, Tel Aviv 6997801, Israel
UI/UX Basch_Interactive